Literature DB >> 20127720

Control of intestinal promoter activity of the cellular migratory regulator gene ELMO3 by CDX2 and SP1.

Mehmet Coskun1, Mette Boyd, Jørgen Olsen, Jesper T Troelsen.   

Abstract

An important aspect of the cellular differentiation in the intestine is the migration of epithelial cells from the crypt to the villus tip. As homeodomaine transcription factor CDX2 has been suggested to influence cell migration, we performed a genome-wide promoter analysis for CDX2 binding in the differentiated human intestinal cancer cell line Caco-2 in order to identify CDX2-regulated genes involved in cellular migration. The engulfment and cell motility 3 (ELMO3) gene was identified as a potential CDX2 target gene. ELMO3 is an essential upstream regulator of the GTP-binding protein RAC during cell migration. However, no information is available about the transcriptional regulation of the ELMO3 gene. The aim of this study was to investigate the potential role of CDX2 in the regulation of the ELMO3 promoter activity. Electrophoretic mobility shift assays showed that CDX2 bound to conserved CDX2 sequences and mutations of the CDX2-binding sites, significantly reduced the promoter activity. Reporter gene assays demonstrated that the region mediating ELMO3 basal transcriptional activity to be located between -270 and -31 bp. Sequence analysis revealed no typical TATA-box, but four GC-rich sequences. In vitro analyses (electrophoretic mobility shift assays and promoter analyses) demonstrate that the SP1-binding sites are likely to play an important role in regulating the ELMO3 promoter activity. Furthermore, we showed here that CDX2 and SP1 can activate the ELMO3 promoter. Taken together, the present study reports the first characterization of the ELMO3 promoter and suggests a significant role of CDX2 in the basal transcriptional regulation of the intestine-specific expression of ELMO3, possibly through interaction with SP1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20127720     DOI: 10.1002/jcb.22490

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  13 in total

1.  ELMO3 expression indicates a poor prognosis in head and neck squamous cell carcinoma - a short report.

Authors:  Lorenz Kadletz; Gregor Heiduschka; Robert Wiebringhaus; Elisabeth Gurnhofer; Ulana Kotowski; Georg Haymerle; Markus Brunner; Conor Barry; Lukas Kenner
Journal:  Cell Oncol (Dordr)       Date:  2016-12-30       Impact factor: 6.730

2.  ELMO3 is a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.

Authors:  Wei Fan; Haikou Yang; Hong Xue; Yong Sun; Jun Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice.

Authors:  Xiujuan Wu; Victoria S Conlin; Vijay Morampudi; Natasha R Ryz; Yasmin Nasser; Ganive Bhinder; Kirk S Bergstrom; Hong B Yu; Chris C M Waterhouse; Allison M J Buchan; Oana E Popescu; William T Gibson; James A Waschek; Bruce A Vallance; Kevan Jacobson
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

4.  Hypomethylation and increased expression of the putative oncogene ELMO3 are associated with lung cancer development and metastases formation.

Authors:  Signe Søes; Iben Lyster Daugaard; Brita Singers Sørensen; Andreas Carus; Manuel Mattheisen; Jan Alsner; Jens Overgaard; Henrik Hager; Lise Lotte Hansen; Lasse Sommer Kristensen
Journal:  Oncoscience       Date:  2014-05-23

5.  Knockdown of ELMO3 Suppresses Growth, Invasion and Metastasis of Colorectal Cancer.

Authors:  Hui-Yun Peng; Qiong-Fang Yu; Wei Shen; Cheng-Ming Guo; Zhen Li; Xiao-Yan Zhou; Nan-Jin Zhou; Wei-Ping Min; Dian Gao
Journal:  Int J Mol Sci       Date:  2016-12-16       Impact factor: 5.923

6.  DNA Methylation Levels of the ELMO Gene Promoter CpG Islands in Human Glioblastomas.

Authors:  Signe Regner Michaelsen; Derya Aslan; Thomas Urup; Hans Skovgaard Poulsen; Kirsten Grønbæk; Helle Broholm; Lasse Sommer Kristensen
Journal:  Int J Mol Sci       Date:  2018-02-28       Impact factor: 5.923

7.  Recurring Translocations in Barrett's Esophageal Adenocarcinoma.

Authors:  Manisha Bajpai; Anshuman Panda; Kristen Birudaraju; James Van Gurp; Amitabh Chak; Kiron M Das; Parisa Javidian; Hana Aviv
Journal:  Front Genet       Date:  2021-06-09       Impact factor: 4.599

8.  Gene expression correlations in human cancer cell lines define molecular interaction networks for epithelial phenotype.

Authors:  Kurt W Kohn; Barry M Zeeberg; William C Reinhold; Yves Pommier
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

9.  Identification of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2.

Authors:  Mette Boyd; Mehmet Coskun; Berit Lilje; Robin Andersson; Ilka Hoof; Jette Bornholdt; Katja Dahlgaard; Jørgen Olsen; Morana Vitezic; Jacob Tveiten Bjerrum; Jakob Benedict Seidelin; Ole Haagen Nielsen; Jesper Thorvald Troelsen; Albin Sandelin
Journal:  DNA Res       Date:  2014-07-02       Impact factor: 4.458

10.  HOXB4 Gene Expression Is Regulated by CDX2 in Intestinal Epithelial Cells.

Authors:  Steffen Jørgensen; Mehmet Coskun; Keld Mikkelsen Homburg; Ole B V Pedersen; Jesper T Troelsen
Journal:  PLoS One       Date:  2016-10-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.